CN1850252A - Method for treating throat cancer - Google Patents
Method for treating throat cancer Download PDFInfo
- Publication number
- CN1850252A CN1850252A CNA2006100424451A CN200610042445A CN1850252A CN 1850252 A CN1850252 A CN 1850252A CN A2006100424451 A CNA2006100424451 A CN A2006100424451A CN 200610042445 A CN200610042445 A CN 200610042445A CN 1850252 A CN1850252 A CN 1850252A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- medicine
- treatment
- laryngocarcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title description 4
- 206010043515 Throat cancer Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 63
- 241000756943 Codonopsis Species 0.000 claims abstract description 14
- 238000011282 treatment Methods 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 27
- 239000002552 dosage form Substances 0.000 claims description 13
- 210000003038 endothelium Anatomy 0.000 claims description 13
- 241000533849 Gleditsia Species 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002398 materia medica Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 2
- 241001523681 Dendrobium Species 0.000 abstract 1
- 241000212941 Glehnia Species 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 241001038563 Pseudostellaria Species 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 17
- 238000012856 packing Methods 0.000 description 16
- 239000012141 concentrate Substances 0.000 description 14
- 210000003800 pharynx Anatomy 0.000 description 14
- 238000005303 weighing Methods 0.000 description 13
- 238000001959 radiotherapy Methods 0.000 description 10
- 210000000867 larynx Anatomy 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 201000009030 Carcinoma Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 201000005264 laryngeal carcinoma Diseases 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 206010065553 Bone marrow failure Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 206010058046 Post procedural complication Diseases 0.000 description 2
- 208000035965 Postoperative Complications Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000023409 throat pain Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022086 Injection site pain Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese medicine for curing laryngocarcinoma. Said Chinese medicine is made up by using 18 Chinese medicinal material of pseudostellaria root, codonopsis root, dendrobium stem, adenophoral glehnia root, ophiopogon tuber and others through a certain preparation process.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of laryngocarcinoma, relate in particular to and a kind ofly be used for the treatment of behind the laryngocarcinoma chemicotherapy and the medicine of postoperative, belong to the field of Chinese medicines.
Background technology
Laryngocarcinoma is one of incidence common cancer, accounts for 1%～2% of whole body malignant tumor, and traditional Chinese medical science ancient books is early on the books to the throat tumor, as " larynx gill fungus ", " sore throat ", " atretolemic abscess " etc., " on steam in larynx, form as bacterium, or hypodynia; or wood and not bitterly, between the infraction larynx, diet hinders." " the secret larynx book of capsule " of the Yang Long of the Qing Dynasty nine: in (larynx BAIYE) throat raw meat is arranged, folded mutually layer by layer, gradually swollen porose, the person that goes out the foul smell.Laryngeal carcinoma belongs to categories such as " carcinoma of the throat ", " atretolemic abscess ", " larynx BAIYE ".Qing Dynasty's height hold political power " Yangke Xinde Ji, Experience Gained in Treating External Diseases ": " carcinoma of the throat is given birth to because of the melancholy stagnation of QI, heat in blood ".Modest " larynx section heart method " is apt in Qing Dynasty Shen: " carcinoma of the throat wind is held gastric heat under the arm by liver-fire and is formed." larynx is the passage of gas, can breathe, main pronunciation belongs to lung.The Liver and kidney channel course so far, if the evil enemy intrusion or invasion of wind heat, Lung Qi obstraction, phlegm-heat internal-node, or do not relax because of feelings will, stagnation of liver-QI is depressed, stagnated QI transforming into fire, blood stasis are gradually given birth to, it is cloudy and be levying of deficiency of both QI and YIN then to consume impairment of QI for a long time.Or because of internal injury caused by excess of seven emotions, deficiency of the liver and kindey, hyperactivity of YANG due to deficiency of YIN, heat and expectorant knot, or because of having a liking for the food rich and fatty diet, taste are wet to be accumulate, and accumulates and heat-transformation, damp and hot stifling.Expectorant, wet, heat, the stasis of blood, poison gather in throat, become to give birth to and lump, and then become carcinoma of the throat.
The treatment of laryngocarcinoma has operation, radiation and chemotherapy, can tolerate operator, answers first-selected operative treatment, postoperative is suitably selected radiation and chemotherapy according to the state of an illness, to late period can not tolerate surgery person, can select radiation and chemotherapy, but need this moment the circulation of qi promoting pipe to cut more with the releasing laryngemphraxis.
Operation, radiation and chemotherapy all can cause injury of throat in various degree, hyperemia, edema, part even total loss of function.Radiotherapy 2 can cause the hyperemia of oral cavity and throat mucosa, pain in week, and salivation reduces, and radiotherapy the pseudomembrane sense can occur after 3 weeks, and mucosa thickens, sense of taste disappearance, even occur that oral cavity and throat ulcer is prolonged not to heal.Chemotherapy can cause gastrointestinal reaction, bone marrow depression, and hepatic and renal function injure, injection site pain even necrosis, cardiac toxicity and nervous symptoms, tumor is is not only killed and wounded oncocyte, also kills and wounds normal cell, causes whole body hypofunction and multiple side effect.Postoperative complication, chemicotherapy toxicity are often repaired by patient self merely, lack at present and promote that effectively the patient recovers the body constitution treatment means, late tumor is often taked to appease measure, previous tretament has spent very big human and material resources and financial resources, successive treatment does not catch up with, curative effect can not be consolidated, and has had a strong impact on patient's quality of life and the existence life-span.Though there are indivedual Chinese physicians to adopt odd Chinese herbal treatment, do not take effectively and the treatment means of system lacks unified management, cause curative effect and be difficult to determine.
Summary of the invention
At the deficiencies in the prior art, the problem to be solved in the present invention provides a kind of medicine for the treatment of laryngocarcinoma, this medicine is the laryngocarcinoma disease to be carried out on the basis of analysis-by-synthesis, according to whole discrimination, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle, utilize state-of-the-art technology and means to carry out that repetition test develops, the patient who reaches postoperative behind the laryngocarcinoma chemicotherapy is had good curing effect and recovery effects, and curative effect is stablized obviously.
The medicine of treatment laryngocarcinoma of the present invention has supplementing QI and nourishing YIN, promote the production of body fluid moisturize, YIN nourishing is supported liquid, the effect of invigorating the spleen for eliminating dampness, pleasant sensible, detoxicating and resolving stagnation of pathogens, expelling remnant toxicity, mainly is to realize by following prescription compatibility:
The drug component of described treatment laryngocarcinoma is: be the medicament of being made by following raw materials by weight proportions
Radix Pseudostellariae 20-40 Radix Codonopsis 20-40 Herba Dendrobii 10-20 Radix Adenophorae (Radix Glehniae) 10-17
Radix Ophiopogonis 10-20 Fructus Crataegi (parched to brown) 10-20 Endothelium Corneum Gigeriae Galli 10-20 Fructus Amomi 10-15
Spica Prunellae 10-15 Herba Hedyotidis Diffusae 15-25 Spina Gleditsiae 10-18 Herba Eupatorii 10-15
Herba Pogostemonis 10-15 Cortex Moutan 10-15 Rhizoma Belamcandae 6-12 Rhizoma Acori Graminei 8-12
Carapax et Plastrum Testudinis 10-15 pollen 20-30.
In the medicine of above-mentioned treatment laryngocarcinoma, the weight proportion of described each crude drug preferably:
Radix Pseudostellariae 30-37 Radix Codonopsis 25-35 Herba Dendrobii 12-18 Radix Adenophorae (Radix Glehniae) 10-15
Radix Ophiopogonis 10-15 Fructus Crataegi (parched to brown) 14-20 Endothelium Corneum Gigeriae Galli 14-20 Fructus Amomi 10-14
Spica Prunellae 10-14 Herba Hedyotidis Diffusae 17-23 Spina Gleditsiae 10-15 Herba Eupatorii 10-14
Herba Pogostemonis 10-14 Cortex Moutan 10-14 Rhizoma Belamcandae 8-11 Rhizoma Acori Graminei 9-11
Carapax et Plastrum Testudinis 12-15 pollen 23-30.
In the medicine of above-mentioned treatment laryngocarcinoma, the weight proportion of described each crude drug most preferably is:
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
Radix Pseudostellariae, Radix Codonopsis are monarch drug tonifying QI to produce body fluid, supplementing QI and nourishing YIN in above-mentioned composition of prescription; Herba Dendrobii, Radix Adenophorae (Radix Glehniae), Radix Ophiopogonis moisturize for the ministerial drug Yin-nourishing and body fluid promoting, strengthen the therapeutical effect of monarch drug; Fructus Crataegi (parched to brown), Endothelium Corneum Gigeriae Galli, Fructus Amomi spleen invigorating, function of spleen and stomach regulating, Spica Prunellae, Herba Hedyotidis Diffusae, Spina Gleditsiae, Herba Eupatorii, Herba Pogostemonis, Cortex Moutan expelling remnant toxicity, removing dampness are eliminating evil; Rhizoma Belamcandae, Rhizoma Acori Graminei are messenger drug, have one's ideas straightened out, the throat medication, make medicine better act on throat, and " tying-in " effect is arranged; Carapax et Plastrum Testudinis has nourishing YIN yin nourishing, hemopoietic, blood tonification effect, and pollen has QI invigorating dispel the wind, stop blooding heat clearing away, the effect of promoting the production of body fluid.All medicines are played the effect of tonifying QI to produce body fluid, supplementing QI and nourishing YIN, invigorating the spleen for eliminating dampness, expelling remnant toxicity altogether.
The dosage form of the medicine of treatment laryngocarcinoma of the present invention is a said dosage form on any pharmacy of Chinese materia medica.
Wherein, above-mentioned said dosage form selection is a peroral dosage form.
Wherein, preferably one of decoction, granule, tablet, capsule, the watered pill, drop pill of above-mentioned said peroral dosage form.
Wherein, further preferably one of decoction, granule, tablet, capsule of above-mentioned said dosage form.
Wherein, above-mentioned said dosage form most preferably is a decoction.
The preparation method that the preparation method of the medicine of the treatment laryngocarcinoma of the invention described above can adopt those skilled in the art to use always is operated.
Wherein: the preparation method of described decoction can be carried out as following method, but is not limited only to this method.
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1～1.5 hour in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 40～60 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.15～1.20 (40 ℃), stops to concentrate, leave standstill 1～2 hour after, with concentrated supernatant with soft-packaged machine with the packing of treatment consumption, conventional sterilization is labelled, packing is promptly made decoction.
The Chinese medicine decoction that the medicine of treatment laryngocarcinoma of the present invention is particularly above-mentioned is used modern crafts and is processed, and not only has anticancer growth diffusion, the mutation curative effect; And can also human body immunity improving power, improve appetite and dietary amount, alleviate post-operative complication, reduce or alleviated side effect that causes by chemotherapy or radiotherapy and the misery of bringing to the patient, improve quality of life, prolonged patient's life-span, improved survival rate; The medicine of treatment laryngocarcinoma of the present invention also has the medical material of saving consumption, saves cost, and the accurate advantage of dosage has alleviated patient economy burden.
Use (5 doses weekly of Drug therapy laryngocarcinoma 340 examples of treatment laryngocarcinoma of the present invention, serve on 5 days, had a rest 2 days, 1 month is a course of treatment), wherein: behind the chemicotherapy, postoperative 280 examples, late period laryngeal carcinoma 60 examples of not performing the operation, through clinical practice and observation, the result shows: chemicotherapy and after-operation response alleviate 260 examples, the tumor person of dwindling 40 examples, tumor is variation person's 20 examples not, effective percentage 88.2%, 5 years survival rates 85% of follow-up observation.
With the medicine of treatment laryngocarcinoma of the present invention and clinical Chinese medicine preparation commonly used such as XIAOAIPING PIAN, the comparison of ginseng one capsule at present, except the remarkable enhancing body cellular immunity of energy, increase outside the whole body anti-tumor capacity, can significantly alleviate the oral mucosa reaction that radiotherapy causes, oral ulcer, ease the pain, the clinical enhancement effect that shows is taken in radiotherapy simultaneously; Can strengthen chemotherapeutic efficacy, alleviate chemical therapy toxic side effect (gastrointestinal reaction, bone marrow depression reaction, nervous symptoms), stimulating appetite, can promote healing postoperative wound surface, alleviate postoperative mucosa reaction and respiratory tract symptom, and low price (daily cost of using the medicine of treatment laryngocarcinoma of the present invention is 52.4% of an XIAOAIPING PIAN only, joins capsular 71.1%).With the existing cancer therapy drug in market relatively, in healing of canker sores, alleviate and stronger advantage is arranged aspect the oral cavity and throat pain, be more satisfactory medicine behind laryngocarcinoma postoperative, the chemicotherapy.
Below in conjunction with concrete clinical control viewing test medicine of the present invention and result of the test thereof are further elaborated.
Use medicine decoction (laryngeal carcinoma soup) treatment laryngocarcinoma 66 examples of treatment laryngocarcinoma of the present invention, use XIAOAIPING PIAN treatment laryngocarcinoma 56 examples, curative effect is compared as follows:
| Laryngeal carcinoma soup | XIAOAIPING PIAN | X 2 | P | |
| Gastrointestinal reaction alleviates blood leucocyte rising canker sore and alleviates oral cavity and throat pain relief feed and put on weight and increase cough and expectoration and alleviate daily cost (unit) | 60 55 48 58 54 45 48 33 | 46 40 21 32 49 30 21 63 | 2.04 3.03 15.3 14.8 0.74 2.73 15.3 | ＞0.05 ＞0.05 ＜0.01 ＜0.01 ＞0.05 ＞0.05 ＜0.01 |
Model case:
Further specify the outstanding effect of medicine in clinical treatment of using treatment laryngocarcinoma of the present invention with model case below.
Name: Liu so-and-so, the man, 70 years old age, the numbering D24.People from Weifang, Shandong.Because of hoarseness, cough, dysphagia is surplus January, comes institute to go to a doctor, be diagnosed as laryngocarcinoma, the immediate surgery treatment, the postoperation radiotherapy moon is surplus, dry pharynx, pain, the symptom of can not taking food occur, take 1 course of treatment of decoction of the present invention, dry pharynx, pain disappear substantially, feed takes a turn for the better, weight increase, body constitution obviously changes, and serve on for 3 courses of treatment again, the back interruption is taken medicine, follow-up observation not recurrence in 5 years.
In a word, the medicine of treatment laryngocarcinoma of the present invention is at the custom-designed a kind of cost-effective treatment by Chinese herbs scheme of the pathological characteristic behind laryngocarcinoma postoperative, the chemicotherapy, can significantly improve local symptom, improves the quality of living.
The specific embodiment
Embodiment 1
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1 hour in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.20 (40 ℃), stops to concentrate, leave standstill 1.5 hours after, with concentrated supernatant with soft-packaged machine with the packing of treatment consumption, conventional sterilization is labelled, packing is promptly made decoction.
Embodiment 2
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 22 Radix Codonopsis 20 Herba Dendrobiis 10 Radix Adenophorae (Radix Glehniae) 10
Radix Ophiopogonis 10 Fructus Crataegi (parched to brown)s, 12 Endothelium Corneum Gigeriae Galli, 11 Fructus Amomis 10
Spica Prunellae 10 Herba Hedyotidis Diffusae 15 Spina Gleditsiaes 11 Herba Eupatoriis 10
Herba Pogostemonis 10 Cortex Moutans 10 Rhizoma Belamcandae 7 Rhizoma Acori Graminei 9
Carapax et Plastrum Testudinis 11 pollen 20.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1 hour in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.18 (40 ℃), stops to concentrate, leave standstill 1 hour after, with concentrated supernatant with soft-packaged machine with the packing of treatment consumption, conventional sterilization is labelled, packing is promptly made decoction.
Embodiment 3
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 40 Radix Codonopsis 40 Herba Dendrobiis 20 Radix Adenophorae (Radix Glehniae) 17
Radix Ophiopogonis 20 Fructus Crataegi (parched to brown)s, 20 Endothelium Corneum Gigeriae Galli, 20 Fructus Amomis 15
Spica Prunellae 15 Herba Hedyotidis Diffusae 25 Spina Gleditsiaes 18 Herba Eupatoriis 15
Herba Pogostemonis 15 Cortex Moutans 15 Rhizoma Belamcandae 12 Rhizoma Acori Gramineis 12
Carapax et Plastrum Testudinis 15 pollen 30.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1.5 hours in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.17 (40 ℃), stops to concentrate, leave standstill 2 hours after, with concentrated supernatant with soft-packaged machine with the packing of treatment consumption, conventional sterilization is labelled, packing is promptly made decoction.
Embodiment 4
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1.5 hours in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.30 (40 ℃), stops to concentrate, leave standstill 2 hours after, with extractum behind the concentrating under reduced pressure and conventional tablet adjuvant mix homogeneously, wet granulation, compacting is (every is equivalent to crude drug 1 gram) in flakes.
Embodiment 5
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1.5 hours in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.30 (40 ℃), stops to concentrate, leave standstill 2 hours after, the conventional method drying is ground into powder with it, the snap fit capsule of packing into (every capsules is equivalent to crude drug 1 gram).
Embodiment 6
Take by weighing each crude drug (unit is in kilogram) by following weight proportion
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
Preparation method is as follows:
Take by weighing each crude drug with the described weight proportion of prescription respectively, divide in the clean sandbag of packing into, insert then and soak 1.5 hours in the retort, decoct respectively 3 times with 1 hour, 40 minutes, 30 minutes clock times, merging 3 times decocting liquid, filter with 50 mesh sieves, is 0.1Kg/cm with the steam pressure
2Condition, the reuse membrane evaporator concentrates decocting liquid, when decocting liquid proportion is 1.30 (40 ℃), stops to concentrate, leave standstill 2 hours after, add conventional adhesive, add starch and make filler, make granule.
Claims (8)
1. a medicine for the treatment of laryngocarcinoma is characterized in that it is the medicament of being made by following raw materials by weight proportions
Radix Pseudostellariae 20-40 Radix Codonopsis 20-40 Herba Dendrobii 10-20 Radix Adenophorae (Radix Glehniae) 10-17
Radix Ophiopogonis 10-20 Fructus Crataegi (parched to brown) 10-20 Endothelium Corneum Gigeriae Galli 10-20 Fructus Amomi 10-15
Spica Prunellae 10-15 Herba Hedyotidis Diffusae 15-25 Spina Gleditsiae 10-18 Herba Eupatorii 10-15
Herba Pogostemonis 10-15 Cortex Moutan 10-15 Rhizoma Belamcandae 6-12 Rhizoma Acori Graminei 8-12
Carapax et Plastrum Testudinis 10-15 pollen 20-30.
2. the medicine of treatment laryngocarcinoma as claimed in claim 1 is characterized in that, the weight proportion of described each crude drug is:
Radix Pseudostellariae 30-37 Radix Codonopsis 25-35 Herba Dendrobii 12-18 Radix Adenophorae (Radix Glehniae) 10-15
Radix Ophiopogonis 10-15 Fructus Crataegi (parched to brown) 14-20 Endothelium Corneum Gigeriae Galli 14-20 Fructus Amomi 10-14
Spica Prunellae 10-14 Herba Hedyotidis Diffusae 17-23 Spina Gleditsiae 10-15 Herba Eupatorii 10-14
Herba Pogostemonis 10-14 Cortex Moutan 10-14 Rhizoma Belamcandae 8-11 Rhizoma Acori Graminei 9-11
Carapax et Plastrum Testudinis 12-15 pollen 23-30.
3. the medicine of treatment laryngocarcinoma as claimed in claim 2 is characterized in that, the weight proportion of described each crude drug is:
Radix Pseudostellariae 32 Radix Codonopsis 30 Herba Dendrobiis 15 Radix Adenophorae (Radix Glehniae) 12
Radix Ophiopogonis 12 Fructus Crataegi (parched to brown)s, 17 Endothelium Corneum Gigeriae Galli, 17 Fructus Amomis 12
Spica Prunellae 12 Herba Hedyotidis Diffusae 20 Spina Gleditsiaes 13 Herba Eupatoriis 12
Herba Pogostemonis 12 Cortex Moutans 12 Rhizoma Belamcandae 9 Rhizoma Acori Graminei 10
Carapax et Plastrum Testudinis 14 pollen 26.
4. as the medicine of claim 1,2 or 3 described treatment laryngocarcinoma, it is characterized in that said medicament is a said dosage form on any pharmacy of Chinese materia medica.
5. the medicine of treatment laryngocarcinoma as claimed in claim 4 is characterized in that, said dosage form is a peroral dosage form.
6. the medicine of treatment laryngocarcinoma as claimed in claim 5 is characterized in that, said peroral dosage form is one of decoction, granule, tablet, capsule, the watered pill, drop pill.
7. the medicine of treatment laryngocarcinoma as claimed in claim 6 is characterized in that, said dosage form is one of decoction, granule, tablet, capsule.
8. the medicine of treatment laryngocarcinoma as claimed in claim 7 is characterized in that, said dosage form is a decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100424451A CN100348260C (en) | 2006-02-28 | 2006-02-28 | Method for treating throat cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100424451A CN100348260C (en) | 2006-02-28 | 2006-02-28 | Method for treating throat cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1850252A true CN1850252A (en) | 2006-10-25 |
| CN100348260C CN100348260C (en) | 2007-11-14 |
Family
ID=37131764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100424451A Expired - Fee Related CN100348260C (en) | 2006-02-28 | 2006-02-28 | Method for treating throat cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100348260C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103215224A (en) * | 2012-01-19 | 2013-07-24 | 中国人民解放军总医院 | Laryngocarcinoma spontaneous cervical lymph nody metastasis animal model |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1289127C (en) * | 2004-12-23 | 2006-12-13 | 黄文珍 | Medicinal composition for treating tumour and its preparation method |
-
2006
- 2006-02-28 CN CNB2006100424451A patent/CN100348260C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103215224A (en) * | 2012-01-19 | 2013-07-24 | 中国人民解放军总医院 | Laryngocarcinoma spontaneous cervical lymph nody metastasis animal model |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100348260C (en) | 2007-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1201793C (en) | Medicine composition for treatment of cough and asthma and preparation thereof | |
| CN101695546B (en) | Chinese medicament for treating alimentary tract cancer and preparation method thereof | |
| CN101062221A (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
| CN1301743C (en) | Chinese medicinal formula for treating chronic bronchitis | |
| CN1232279C (en) | Antilipemic Chinese medicine | |
| CN1233354C (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1660387A (en) | Health care preparation for regulating functional balance of organs of bowels in human body and preparing method | |
| CN101028488A (en) | Chinese medicine for chronic pharyngitis, esophagus inflammation and esophagus cancer | |
| CN1850252A (en) | Method for treating throat cancer | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN101049464A (en) | Preparation of Chinese traditional medicine in use for tumor, and preparation method | |
| CN1730093A (en) | Chinese traditional medicine preparation for treating cancer and application thereof | |
| CN1586297A (en) | Body building health preparation and its producing method | |
| CN1814163A (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
| CN101028451A (en) | Chinese medicine for treating tic douloureux | |
| CN1857660A (en) | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN101618187A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN102488807A (en) | Medicine for treating asthma | |
| CN102225159A (en) | Traditional Chinese medicine compound for treating diseases such as nephritis, renal failure and uremia and preparation thereof | |
| CN1217688C (en) | Medicine for treating chronic gastritis and preparing process thereof | |
| CN101066291A (en) | Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn | |
| CN1742960A (en) | Chuanluotong Chinese medicine preparation and preparing method thereof | |
| CN1217196A (en) | Edible salt substitute for treating kidney disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151021 Address after: Huaiyin District of Ji'nan City, Shandong province 250117 Yan Ji Road, No. 440 Patentee after: Shandong Tumor Hospital Address before: Huaiyin District of Ji'nan City, Shandong province 250117 Yan Ji Road, No. 440 Patentee before: Chen Wanjun |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071114 Termination date: 20160228 |